Trends in Vaccination Coverage among Children Aged 2–6 Years in Tennessee Counties, 2017–2023
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Population and Data Sources
2.2. Data Analysis
3. Results
3.1. Age Group 2–3 Years
3.2. Age Group 4–6 Years
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Filip, R.; Gheorghita Puscaselu, R.; Anchidin-Norocel, L.; Dimian, M.; Savage, W.K. Global Challenges to Public Health Care Systems during the COVID-19 Pandemic: A Review of Pandemic Measures and Problems. J. Pers. Med. 2022, 12, 1295. [Google Scholar] [CrossRef] [PubMed]
- Basu, S.; Ashok, G.; Debroy, R.; Ramaiah, S.; Livingstone, P.; Anbarasu, A. Impact of the COVID-19 pandemic on routine vaccine landscape: A global perspective. Hum. Vaccin. Immunother. 2023, 19, 2199656. [Google Scholar] [CrossRef] [PubMed]
- Kao, C.M.; Schneyer, R.J.; Bocchini, J.A., Jr. Child and adolescent immunizations: Selected review of recent US recommendations and literature. Curr. Opin. Pediatr. 2014, 26, 383–395. [Google Scholar] [CrossRef] [PubMed]
- Lassi, Z.S.; Naseem, R.; Salam, R.A.; Siddiqui, F.; Das, J.K. The Impact of the COVID-19 Pandemic on Immunization Campaigns and Programs: A Systematic Review. Int. J. Environ. Res. Public Health 2021, 18, 988. [Google Scholar] [CrossRef]
- Alfieri, N.L.; Kusma, J.D.; Heard-Garris, N.; Davis, M.M.; Golbeck, E.; Barrera, L.; Macy, M.L. Parental COVID-19 vaccine hesitancy for children: Vulnerability in an urban hotspot. BMC Public Health 2021, 21, 1662. [Google Scholar] [CrossRef]
- Santoli, J.M.; Huet, N.J.; Smith, P.J.; Barker, L.E.; Rodewald, L.E.; Inkelas, M.; Olson, L.M.; Halfon, N. Insurance Status and Vaccination Coverage among US Preschool Children. Pediatrics 2004, 113 (Suppl. S5), 1959–1964. [Google Scholar] [CrossRef]
- Lakew, Y.; Bekele, A.; Biadgilign, S. Factors influencing full immunization coverage among 12–23 months of age children in Ethiopia: Evidence from the national demographic and health survey in 2011. BMC Public Health 2015, 15, 728. [Google Scholar] [CrossRef]
- Vandermeulen, C.; Roelants, M.; Theeten, H.; Van Damme, P.; Hoppenbrouwers, K. Vaccination coverage and sociodemographic determinants of measles–mumps–rubella vaccination in three different age groups. Eur. J. Pediatr. 2008, 167, 1161–1168. [Google Scholar] [CrossRef]
- Waldhoer, T.; Haidinger, G.; Vutuc, C.; Haschke, F.; Plank, R. The impact of sociodemographic variables on immunization coverage of children. Eur. J. Epidemiol. 1997, 13, 145–149. [Google Scholar] [CrossRef]
- Mueller, J.T.; McConnell, K.; Burow, P.B.; Pofahl, K.; Merdjanoff, A.A.; Farrell, J. Impacts of the COVID-19 pandemic on rural America. Proc. Natl. Acad. Sci. USA 2021, 118, 2019378118. [Google Scholar] [CrossRef]
- Anaraki, N.R.; Mukhopadhyay, M.; Karaivanov, Y.; Wilson, M.; Asghari, S. Living and working in rural healthcare during the COVID-19 pandemic: A qualitative study of rural family physicians’ lived experiences. BMC Prim. Care 2022, 23, 335. [Google Scholar] [CrossRef] [PubMed]
- Chu, C.; Cram, P.; Pang, A.; Stamenova, V.; Tadrous, M.; Bhatia, R.S. Rural Telemedicine Use Before and During the COVID-19 Pandemic: Repeated Cross-sectional Study. J. Med. Internet Res. 2021, 23, e26960. [Google Scholar] [CrossRef] [PubMed]
- Cuadros, D.F.; Branscum, A.J.; Mukandavire, Z.; Miller, F.D.; MacKinnon, N. Dynamics of the COVID-19 epidemic in urban and rural areas in the United States. Ann. Epidemiol. 2021, 59, 16–20. [Google Scholar] [CrossRef] [PubMed]
- Rifat, S.A.A.; Liu, W. One year into the pandemic: The impacts of social vulnerability on COVID-19 outcomes and urban–rural differences in the conterminous United States. Int. J. Environ. Health Res. 2022, 32, 2601–2619. [Google Scholar] [CrossRef] [PubMed]
- Peters, D.J. Community Susceptibility and Resiliency to COVID-19 Across the Rural-Urban Continuum in the United States. J. Rural Health 2020, 36, 446–456. [Google Scholar] [CrossRef]
- Segel, J.E.; Ross, H.I.; Edwards, J.L.; Braun, K.A.; Davis, L.A. The Unique Challenges Facing Rural Providers in the COVID-19 Pandemic. Popul. Health Manag. 2020, 24, 304–306. [Google Scholar] [CrossRef]
- Nuzhath, T.; Ajayi, K.V.; Fan, Q.; Hotez, P.; Colwell, B.; Callaghan, T.; Regan, A.K. Childhood immunization during the COVID-19 pandemic in Texas. Vaccine 2021, 39, 3333–3337. [Google Scholar] [CrossRef]
- Spencer, N.; Markham, W.; Johnson, S.; Arpin, E.; Nathawad, R.; Gunnlaugsson, G.; Homaira, N.; Rubio, M.L.; Trujillo, C.J. The Impact of COVID-19 Pandemic on Inequity in Routine Childhood Vaccination Coverage: A Systematic Review. Vaccines 2022, 10, 1013. [Google Scholar] [CrossRef]
- Maltezou, H.C.; Medic, S.; Cassimos, D.C.; Effraimidou, E.; Poland, G.A. Decreasing routine vaccination rates in children in the COVID-19 era. Vaccine 2022, 40, 2525–2527. [Google Scholar] [CrossRef]
- DeSilva, M.B.; Haapala, J.; Vazquez-Benitez, G.; Daley, M.F.; Nordin, J.D.; Klein, N.P.; Henninger, M.L.; Williams, J.T.B.; Hambidge, S.J.; Jackson, M.L.; et al. Association of the COVID-19 Pandemic With Routine Childhood Vaccination Rates and Proportion Up to Date with Vaccinations across 8 US Health Systems in the Vaccine Safety Datalink. JAMA Pediatr. 2022, 176, 68–77. [Google Scholar] [CrossRef]
- CDC. ACIP Vaccine Recommendations | CDC. 2023. Available online: https://www.cdc.gov/vaccines/acip/recommendations.html (accessed on 7 June 2024).
- TN Department of Health. Tennessee Immunization Information System (TennIIS). Registry, Communicable and Environmental Diseases and Emergency Preparedness Weekly Reports. 2024. Available online: https://www.tn.gov/health/ceds-weeklyreports.html (accessed on 5 May 2024).
- TN Office of the Governor. COVID-19 Timeline. 2024. Available online: https://www.tn.gov/governor/covid-19/covid19timeline.html (accessed on 17 June 2024).
- USDA. ERS—Rural-Urban Continuum Codes. 2023. Available online: https://www.ers.usda.gov/data-products/rural-urban-continuum-codes/ (accessed on 17 May 2024).
- Seither, R.; Yusuf, O.B.; Dramann, D.; Calhoun, K.; Mugerwa-Kasujja, A.; Knighton, C.L. Coverage with Selected Vaccines and Exemption from School Vaccine Requirements among Children in Kindergarten—United States, 2022–2023 School Year. MMWR Morb. Mortal. Wkly. Rep. 2023, 72, 1217–1224. [Google Scholar] [CrossRef] [PubMed]
- Hill, H.A.; Chen, M.; Elam-Evans, L.D.; Yankey, D.; Singleton, J.A. Vaccination Coverage by Age 24 Months Among Children Born during 2018–2019—National Immunization Survey–Child, United States, 2019–2021. MMWR Morb. Mortal. Wkly. Rep. 2023, 72, 33–38. [Google Scholar] [CrossRef] [PubMed]
- Fogel, B.; Schaefer, E.W.; Hicks, S.D. Early influenza vaccination rates decline in children during the COVID-19 pandemic. Vaccine 2021, 39, 4291–4295. [Google Scholar] [CrossRef] [PubMed]
- Hill, H.A.; Yankey, D.; Elam-Evans, L.D.; Singleton, J.A.; Sterrett, N. Vaccination Coverage by Age 24 Months Among Children Born in 2017 and 2018—National Immunization Survey-Child, United States, 2018–2020. MMWR Morb. Mortal. Wkly. Rep. 2021, 70, 1435–1440. [Google Scholar] [CrossRef]
- Murthy, B.P.; Zell, E.; Kirtland, K.; Jones-Jack, N.; Harris, L.; Sprague, C.; Schultz, J.; Le, Q.; Bramer, C.r.A.; Kuramoto, S.; et al. Impact of the COVID-19 Pandemic on Administration of Selected Routine Childhood and Adolescent Vaccinations—10 U.S. Jurisdictions, March–September 2020. MMWR Morb. Mortal. Wkly. Rep. 2021, 70, 840–845. [Google Scholar] [CrossRef]
- CDC. NIS Data, Tables, and Documentation. 2024. Available online: https://hcup-us.ahrq.gov/db/nation/nis/nisdbdocumentation.jsp (accessed on 21 July 2024).
Vaccine Name | Vaccine Preventable Disease(s) | No. of Doses (2–3 Year) 1 | No. of Doses (4–6 Year) 2 | Possible Complications of Disease |
---|---|---|---|---|
DTaP | Diphtheria, Tetanus, and Pertussis | 4 doses | 5 doses | Diphtheria: Upper airway obstruction, pneumonia, respiratory failure, and death. Tetanus: Spasms of respiratory and skeletal muscles, death Pertussis: Severe, long-term cough, vomiting, breathlessness, death in infants |
Flu | Influenza | At least one | At least one | Secondary pneumonia, exacerbation of chronic diseases, hospitalization, death |
Hep A | Hepatitis A | 2 doses | 2 doses | Fever, nausea, jaundice, death |
Hep B | Hepatitis B | 3 doses | 3 doses | Fulminant hepatitis, jaundice, liver cancer, cirrhosis, premature death |
Hib | Haemophilus influenzae type B | 3–4 doses | 3–4 doses | Pneumonia, meningitis, neurologic problems, death |
IPV | Poliomyelitis | 3 doses | 4 doses | Paralysis, death |
MMR | Measles, Mumps, and Rubella | 1 dose | 2 doses | Measles: ear infections, pneumonia, cardiac and neurologic problems, encephalitis, death Mumps: decreased fertility, meningitis, arthritis, hearing impairment Rubella: arthritis, encephalitis, birth defect |
PCV | Pneumococcus | 4 doses | 4 doses | Ear infections, pneumonia, meningitis, blood stream infections, death |
Rotavirus | Rotavirus | 2–3 doses | 2–3 doses | Dehydration, hospitalization, death |
VAR | Varicella/Chickenpox | 1 dose | 2 doses | Rash illness, severe disease in immunocompromised, birth defects, encephalitis, death |
Average Vaccine Coverage and 95% CI | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vaccine Name 1 | COVID Pandemic Periods 2 | Sex | Race/Ethnicity | ||||||||||||||||||||||||
Rural counties 3 | P1 | 95% CI | P2 | 95% CI | P3 | 95% CI | Male | 95% CI | Female | 95% CI | White | 95% CI | Black | 95% CI | Hispanic | 95% CI | Non-Hispanic | 95% CI | |||||||||
DTaP | 49.4 | 49.0 | 49.8 | 45.9 | 45.4 | 46.4 | 41.8 | 41.4 | 42.1 | 45.8 | 45.5 | 46.1 | 46.3 | 46.0 | 46.5 | 42.8 | 42.5 | 43.1 | 43.0 | 42.3 | 43.7 | 45.0 | 44.5 | 45.5 | 46.3 | 46.1 | 46.6 |
Daycare Series | 32.3 | 32.0 | 32.6 | 30.9 | 30.4 | 31.3 | 27.6 | 27.3 | 28.0 | 30.4 | 30.1 | 30.6 | 30.5 | 30.2 | 30.7 | 28.8 | 28.6 | 29.0 | 26.9 | 26.4 | 27.4 | 28.1 | 27.8 | 28.5 | 30.8 | 30.5 | 31.0 |
Flu | 20.3 | 20.0 | 20.5 | 22.1 | 21.8 | 22.5 | 16.6 | 16.3 | 16.9 | 19.5 | 19.3 | 19.7 | 19.3 | 19.1 | 19.5 | 23.3 | 23.0 | 23.5 | 16.0 | 15.5 | 16.5 | 26.0 | 25.6 | 26.4 | 19.4 | 19.2 | 19.6 |
Hep A | 37.5 | 37.2 | 37.8 | 35.3 | 34.8 | 35.7 | 32.4 | 32.1 | 32.8 | 35.2 | 35.0 | 35.4 | 35.4 | 35.2 | 35.6 | 34.1 | 33.9 | 34.3 | 31.7 | 31.2 | 32.2 | 32.8 | 32.4 | 33.2 | 35.7 | 35.5 | 35.9 |
Hep B | 53.6 | 53.1 | 54.0 | 49.7 | 49.2 | 50.3 | 45.7 | 45.4 | 46.1 | 49.9 | 49.6 | 50.2 | 50.3 | 50.0 | 50.6 | 46.4 | 46.1 | 46.7 | 45.9 | 45.2 | 46.6 | 49.2 | 48.6 | 49.7 | 50.4 | 50.1 | 50.6 |
Hib | 44.8 | 44.5 | 45.2 | 41.4 | 40.8 | 41.9 | 36.6 | 36.2 | 36.9 | 41.2 | 40.9 | 41.5 | 41.3 | 41.0 | 41.6 | 38.4 | 38.1 | 38.6 | 36.8 | 36.2 | 37.4 | 41.2 | 40.7 | 41.7 | 41.5 | 41.2 | 41.7 |
IPV | 52.8 | 52.4 | 53.2 | 48.9 | 48.3 | 49.4 | 44.8 | 44.4 | 45.1 | 49.0 | 48.7 | 49.3 | 49.4 | 49.2 | 49.7 | 45.5 | 45.2 | 45.8 | 44.6 | 43.9 | 45.2 | 48.3 | 47.8 | 48.9 | 49.5 | 49.2 | 49.8 |
MMR | 52.1 | 51.7 | 52.5 | 48.3 | 47.8 | 48.8 | 44.1 | 43.7 | 44.4 | 48.5 | 48.2 | 48.8 | 48.6 | 48.3 | 48.9 | 45.3 | 45.0 | 45.5 | 44.8 | 44.1 | 45.4 | 47.6 | 47.1 | 48.2 | 48.8 | 48.6 | 49.1 |
PCV | 51.2 | 50.8 | 51.6 | 46.3 | 45.8 | 46.8 | 42.3 | 42.0 | 42.7 | 47.1 | 46.8 | 47.3 | 47.2 | 46.9 | 47.5 | 44.2 | 44.0 | 44.5 | 43.9 | 43.3 | 44.6 | 44.7 | 44.2 | 45.2 | 47.5 | 47.3 | 47.8 |
Rotavirus | 37.8 | 37.4 | 38.1 | 37.5 | 37.1 | 38.0 | 34.8 | 34.5 | 35.1 | 36.4 | 36.2 | 36.7 | 37.0 | 36.8 | 37.3 | 35.8 | 35.6 | 36.1 | 32.9 | 32.3 | 33.5 | 36.1 | 35.6 | 36.5 | 37.0 | 36.8 | 37.2 |
VAR | 51.6 | 51.2 | 52.0 | 47.8 | 47.3 | 48.3 | 43.7 | 43.4 | 44.1 | 48.0 | 47.8 | 48.3 | 48.1 | 47.9 | 48.4 | 44.6 | 44.4 | 44.9 | 44.3 | 43.7 | 45.0 | 43.7 | 43.2 | 44.2 | 48.6 | 48.4 | 48.9 |
Urban Counties 3 | P1 | 95% CI | P2 | 95% CI | P3 | 95% CI | Male | 95% CI | Female | 95% CI | White | 95% CI | Black | 95% CI | Hispanic | 95% CI | Non-Hispanic | 95% CI | |||||||||
DTaP | 48.9 | 48.5 | 49.3 | 47.3 | 46.8 | 47.8 | 42.3 | 41.9 | 42.6 | 46.3 | 46.0 | 46.6 | 46.3 | 46.0 | 46.5 | 44.4 | 44.1 | 44.6 | 42.1 | 41.4 | 42.9 | 41.2 | 40.0 | 42.4 | 46.2 | 45.9 | 46.4 |
Daycare Series | 31.6 | 31.2 | 31.9 | 32.1 | 31.6 | 32.5 | 28.9 | 28.6 | 29.2 | 30.8 | 30.6 | 31.1 | 30.7 | 30.4 | 30.9 | 29.6 | 29.3 | 29.8 | 26.1 | 25.6 | 26.7 | 24.5 | 23.9 | 25.2 | 30.9 | 30.6 | 31.1 |
Flu | 24.0 | 23.7 | 24.4 | 27.7 | 27.3 | 28.2 | 22.6 | 22.2 | 23.0 | 24.4 | 24.2 | 24.7 | 24.2 | 23.9 | 24.4 | 19.1 | 18.9 | 19.3 | 19.1 | 18.7 | 19.5 | 19.0 | 18.4 | 19.5 | 24.0 | 23.7 | 24.2 |
Hep A | 38.0 | 37.7 | 38.3 | 37.1 | 36.6 | 37.5 | 34.0 | 33.6 | 34.3 | 36.5 | 36.3 | 36.7 | 36.3 | 36.1 | 36.6 | 34.3 | 34.1 | 34.5 | 31.4 | 30.7 | 32.1 | 29.4 | 28.4 | 30.3 | 36.6 | 36.4 | 36.9 |
Hep B | 52.9 | 52.5 | 53.3 | 50.7 | 50.2 | 51.2 | 45.5 | 45.1 | 45.9 | 49.9 | 49.6 | 50.2 | 49.9 | 49.6 | 50.2 | 48.6 | 48.3 | 48.8 | 45.5 | 44.7 | 46.3 | 44.8 | 43.6 | 45.9 | 49.7 | 49.5 | 50.0 |
Hib | 43.7 | 43.3 | 44.1 | 42.5 | 42.0 | 43.0 | 37.4 | 37.0 | 37.8 | 41.3 | 41.1 | 41.6 | 41.2 | 40.9 | 41.5 | 40.0 | 39.7 | 40.2 | 36.9 | 36.2 | 37.6 | 37.0 | 36.0 | 38.1 | 41.1 | 40.8 | 41.3 |
IPV | 51.9 | 51.5 | 52.3 | 49.7 | 49.2 | 50.2 | 44.3 | 43.9 | 44.7 | 48.8 | 48.6 | 49.1 | 48.8 | 48.5 | 49.1 | 47.8 | 47.5 | 48.0 | 44.9 | 44.0 | 45.7 | 44.4 | 43.2 | 45.6 | 48.6 | 48.4 | 48.9 |
MMR | 51.9 | 51.5 | 52.3 | 49.4 | 49.0 | 49.9 | 44.1 | 43.8 | 44.5 | 48.8 | 48.5 | 49.0 | 48.7 | 48.4 | 48.9 | 47.0 | 46.8 | 47.3 | 44.4 | 43.6 | 45.2 | 43.3 | 42.1 | 44.5 | 48.6 | 48.3 | 48.8 |
PCV | 51.0 | 50.7 | 51.4 | 48.0 | 47.5 | 48.4 | 42.7 | 42.3 | 43.1 | 47.6 | 47.3 | 47.9 | 47.4 | 47.2 | 47.7 | 45.7 | 45.4 | 46.0 | 43.0 | 42.2 | 43.8 | 41.0 | 39.8 | 42.1 | 47.6 | 47.3 | 47.8 |
Rotavirus | 38.9 | 38.6 | 39.3 | 39.5 | 39.0 | 39.9 | 35.8 | 35.5 | 36.2 | 38.0 | 37.7 | 38.2 | 38.0 | 37.8 | 38.2 | 35.8 | 35.6 | 36.0 | 31.8 | 31.2 | 32.4 | 32.4 | 31.4 | 33.4 | 38.0 | 37.7 | 38.2 |
VAR | 51.0 | 50.7 | 51.4 | 48.8 | 48.3 | 49.2 | 43.7 | 43.4 | 44.1 | 48.1 | 47.9 | 48.4 | 48.0 | 47.7 | 48.2 | 46.6 | 46.3 | 46.8 | 44.4 | 43.6 | 45.2 | 40.4 | 39.2 | 41.6 | 48.3 | 48.0 | 48.6 |
Average Vaccine Coverage and 95% CI | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vaccine Name 1 | COVID Pandemic Periods 2 | Sex | Race/Ethnicity | ||||||||||||||||||||||||
Rural counties 3 | P1 | 95% CI | P2 | 95% CI | P3 | 95% CI | Male | 95% CI | Female | 95% CI | White | 95% CI | Black | 95% CI | Hispanic | 95% CI | Non-Hispanic | 95% CI | |||||||||
DTaP | 77.6 | 76.9 | 78.3 | 73.9 | 73.0 | 74.9 | 70.5 | 69.8 | 71.2 | 70.6 | 70.2 | 71.0 | 70.9 | 70.4 | 71.3 | 62.4 | 62.0 | 62.8 | 66.3 | 65.4 | 67.2 | 64.7 | 63.6 | 65.9 | 70.1 | 69.7 | 70.6 |
Flu | 15.2 | 14.9 | 15.4 | 17.8 | 17.4 | 18.2 | 11.9 | 11.6 | 12.1 | 19.4 | 19.2 | 19.6 | 19.3 | 19.0 | 19.5 | 17.4 | 17.1 | 17.6 | 13.7 | 13.3 | 14.0 | 15.3 | 15.0 | 15.7 | 18.9 | 18.6 | 19.1 |
Hep A | 98.3 | 97.6 | 99.1 | 96.9 | 95.8 | 97.9 | 92.8 | 92.0 | 93.6 | 93.6 | 93.1 | 94.1 | 93.8 | 93.3 | 94.3 | 82.8 | 82.3 | 83.3 | 86.7 | 85.5 | 88.0 | 75.8 | 74.4 | 77.2 | 94.4 | 93.9 | 94.9 |
IPV | 80.3 | 79.6 | 81.0 | 76.6 | 75.6 | 77.5 | 73.1 | 72.4 | 73.8 | 72.9 | 72.5 | 73.4 | 73.2 | 72.8 | 73.6 | 64.5 | 64.0 | 64.9 | 69.4 | 68.3 | 70.5 | 65.2 | 64.0 | 66.3 | 72.7 | 72.3 | 73.2 |
Kindergarten | 69.8 | 69.1 | 70.4 | 68.5 | 67.6 | 69.4 | 66.0 | 65.3 | 66.7 | 62.8 | 62.4 | 63.2 | 63.0 | 62.6 | 63.5 | 55.5 | 55.1 | 55.9 | 60.4 | 59.5 | 61.3 | 54.3 | 53.3 | 55.3 | 62.9 | 62.5 | 63.4 |
MMR | 82.5 | 81.8 | 83.2 | 79.2 | 78.2 | 80.1 | 75.4 | 74.7 | 76.1 | 76.3 | 75.9 | 76.7 | 76.7 | 76.3 | 77.2 | 67.6 | 67.2 | 68.0 | 71.6 | 70.6 | 72.7 | 67.8 | 66.6 | 68.9 | 76.0 | 75.6 | 76.5 |
VAR | 81.8 | 81.1 | 82.5 | 78.3 | 77.3 | 79.2 | 74.6 | 73.9 | 75.3 | 75.1 | 74.6 | 75.5 | 75.4 | 75.0 | 75.9 | 66.3 | 65.9 | 66.8 | 71.8 | 70.8 | 72.9 | 63.9 | 62.8 | 65.1 | 75.3 | 74.9 | 75.8 |
Urban counties 3 | P1 | 95% CI | P2 | 95% CI | P3 | 95% CI | Male | 95% CI | Female | 95% CI | White | 95% CI | Black | 95% CI | Hispanic | 95% CI | Non-Hispanic | 95% CI | |||||||||
DTaP | 72.7 | 72.0 | 73.4 | 69.7 | 68.7 | 70.6 | 68.8 | 68.2 | 69.5 | 74.2 | 73.7 | 74.7 | 74.6 | 74.2 | 75.1 | 69.1 | 68.7 | 69.5 | 66.9 | 65.9 | 67.8 | 71.0 | 70.1 | 71.9 | 74.8 | 74.4 | 75.3 |
Flu | 18.4 | 18.0 | 18.7 | 23.2 | 22.7 | 23.8 | 18.2 | 17.8 | 18.6 | 14.7 | 14.5 | 14.9 | 14.5 | 14.3 | 14.6 | 13.6 | 13.4 | 13.7 | 9.7 | 9.4 | 10.0 | 21.8 | 21.3 | 22.2 | 14.5 | 14.3 | 14.6 |
Hep A | 94.5 | 93.7 | 95.3 | 94.2 | 93.1 | 95.3 | 92.3 | 91.6 | 93.1 | 96.0 | 95.4 | 96.5 | 96.4 | 95.9 | 96.8 | 89.4 | 88.9 | 89.9 | 89.3 | 88.0 | 90.5 | 81.8 | 80.9 | 82.7 | 97.4 | 96.9 | 97.9 |
IPV | 75.0 | 74.3 | 75.7 | 72.0 | 71.1 | 72.9 | 71.2 | 70.5 | 71.8 | 76.9 | 76.4 | 77.3 | 77.3 | 76.8 | 77.8 | 71.7 | 71.2 | 72.1 | 70.9 | 69.9 | 72.0 | 70.4 | 69.5 | 71.2 | 77.7 | 77.2 | 78.1 |
Kindergarten | 63.0 | 62.3 | 63.7 | 62.9 | 62.0 | 63.9 | 62.8 | 62.1 | 63.4 | 68.0 | 67.5 | 68.4 | 68.5 | 68.1 | 68.9 | 63.3 | 62.9 | 63.8 | 62.6 | 61.7 | 63.5 | 57.9 | 57.2 | 58.5 | 69.0 | 68.6 | 69.5 |
MMR | 78.3 | 77.7 | 79.0 | 75.7 | 74.8 | 76.7 | 74.6 | 74.0 | 75.2 | 79.2 | 78.8 | 79.7 | 79.6 | 79.1 | 80.0 | 73.8 | 73.3 | 74.2 | 73.2 | 72.2 | 74.2 | 75.4 | 74.5 | 76.3 | 79.9 | 79.5 | 80.4 |
VAR | 77.0 | 76.3 | 77.7 | 74.5 | 73.6 | 75.4 | 73.4 | 72.8 | 74.0 | 78.5 | 78.0 | 78.9 | 78.8 | 78.3 | 79.2 | 73.0 | 72.5 | 73.4 | 73.3 | 72.2 | 74.3 | 69.4 | 68.6 | 70.2 | 79.5 | 79.0 | 79.9 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Alali, W.Q.; Huang, Q.; Goodin, K.; Gonzalez-Lozano, A. Trends in Vaccination Coverage among Children Aged 2–6 Years in Tennessee Counties, 2017–2023. Vaccines 2024, 12, 1048. https://doi.org/10.3390/vaccines12091048
Alali WQ, Huang Q, Goodin K, Gonzalez-Lozano A. Trends in Vaccination Coverage among Children Aged 2–6 Years in Tennessee Counties, 2017–2023. Vaccines. 2024; 12(9):1048. https://doi.org/10.3390/vaccines12091048
Chicago/Turabian StyleAlali, Walid Q., Qian Huang, Kate Goodin, and Adrian Gonzalez-Lozano. 2024. "Trends in Vaccination Coverage among Children Aged 2–6 Years in Tennessee Counties, 2017–2023" Vaccines 12, no. 9: 1048. https://doi.org/10.3390/vaccines12091048
APA StyleAlali, W. Q., Huang, Q., Goodin, K., & Gonzalez-Lozano, A. (2024). Trends in Vaccination Coverage among Children Aged 2–6 Years in Tennessee Counties, 2017–2023. Vaccines, 12(9), 1048. https://doi.org/10.3390/vaccines12091048